These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 238716)

  • 41. A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris.
    Armstrong ML; Brand D; Emmett AJ; Hodge JL; Kellaway GS; Mestitz P; Reefman M; Wallace DC
    Med J Aust; 1974 Sep; 2(11):389-93. PubMed ID: 4154390
    [No Abstract]   [Full Text] [Related]  

  • 42. Glyceryl trinitrate ointment in angina pectoris.
    Salem HH; Singh SP
    Postgrad Med J; 1979 Dec; 55(654):874-6. PubMed ID: 121456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose response effectiveness of propranolol for the treatment of angina pectoris.
    Alderman EL; Davies RO; Crowley JJ; Lopes MG; Brooker JZ; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Circulation; 1975 Jun; 51(6):964-75. PubMed ID: 805675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
    Westheim AS; Christensen CC; Kjekshus J
    Eur J Clin Pharmacol; 1978 May; 13(3):157-62. PubMed ID: 27370
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of diltiazem and atenolol in angina.
    Wheatley D
    Postgrad Med J; 1985 Sep; 61(719):785-9. PubMed ID: 3903709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of beta blockade and-or physical training in patients with angina pectoris.
    Malmborg RO; Isacsson SO; Kallivroussis G
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):171-83. PubMed ID: 4150633
    [No Abstract]   [Full Text] [Related]  

  • 49. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind, double cross-over trial of prenylamine in angina pectoris.
    Winsor R; Bleifer K; Cole S; Goldman IR; Karpman H; Oblath R; Stone S
    Am Heart J; 1971 Jul; 82(1):43-54. PubMed ID: 4996509
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
    Keyriläinen O; Uusitalo A
    Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of practolol in the treatment of angina pectoris.
    Sen PK; Mukerjee AB
    J Indian Med Assoc; 1974 Oct; 63(8):260-1. PubMed ID: 4216606
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative effects of placebo and sustained-release nitroglycerin in anginal subjects. Preliminary report.
    Wendkos MH; Meshulam N
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):160-6. PubMed ID: 4632473
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rational usage of orally administrated nitroglycerin in angina pectoris].
    Winsor T
    Lakartidningen; 1973 Oct; 70(40):3429-30. PubMed ID: 4207559
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.